Back to top

medical: Archive

Ethan Feller

Bull of the Day: Hims & Hers Health (HIMS)

Hims & Hers Health stock continues to be a market leader even amid controversy

HIMSNegative Net Change

Zacks Equity Research

Implied Volatility Surging for Molina Healthcare Stock Options

Investors need to pay close attention to MOH stock based on the movements in the options market lately.

MOHNegative Net Change

Zacks Equity Research

MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success

Merus jumps 30% in three months after its cancer combo therapy showed significant efficacy in a phase II head and neck squamous cell carcinoma study.

MRKNegative Net Change BAYRYNegative Net Change MRUSNegative Net Change VRNANegative Net Change

Kaibalya Pravo Dey

UnitedHealth vs. Cigna: Which Insurer to Buy Amid Sector Turmoil?

CI's commercial focus and clearer outlook set it apart as UNH faces guidance pulls, CEO change and rising medical costs.

UNHPositive Net Change CINegative Net Change CNCNegative Net Change

Zacks Equity Research

Bayer Wins Hormone-Free Treatment Approval for Women in the UK

BAYRY secures first global approval for Lynkuet in the UK, a hormone-free treatment for menopause-related hot flashes.

NVSNegative Net Change JNJNegative Net Change BAYRYNegative Net Change

Ekta Bagri

ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?

AbbVie edges ahead of Bristol Myers with strong Skyrizi and Rinvoq growth, offsetting Humira declines and portfolio headwinds.

BMYNegative Net Change ABBVNegative Net Change

Zacks Equity Research

InspireMD Launches CGuard Prime Carotid Stent System in the U.S.

NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.

CORNegative Net Change NSPRNegative Net Change ITGRNegative Net Change HIMSNegative Net Change

Urmimala Biswas

Smart Money Going in Senior Health: Key Stocks in Elderly Care

RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand.

ABTNegative Net Change RHHBYNegative Net Change NVONegative Net Change MDTPositive Net Change SYKNegative Net Change EWNegative Net Change

Sundeep Ganoria

Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?

LLY rides high on surging demand for Mounjaro and Zepbound, now nearly half its revenues ahead of Q2 earnings.

NVONegative Net Change LLYPositive Net Change VKTXNegative Net Change

Zacks Equity Research

Here's Why You Should Add Cencora Stock to Your Portfolio Now

COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.

CVSNegative Net Change CORNegative Net Change CODXNegative Net Change WGSNegative Net Change

Indrajit Bandyopadhyay

OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?

OPRX doubles down on AI and subscriptions, but margin mix and retention risks loom over its platform transformation.

OPRXNegative Net Change HSTMNegative Net Change DOCSPositive Net Change

Sridatri Sarkar

3 AI-Driven Medical Device Stocks to Watch in 2025

BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.

BSXNegative Net Change JNJNegative Net Change ISRGNegative Net Change NVDAPositive Net Change GEHCNegative Net Change

Sundeep Ganoria

Cannabis Stock Cresco Labs Plunges 24% YTD: Time to Sell or Hold?

CRLBF is down 24% YTD as U.S.-only exposure, falling margins and tighter regulations weigh on its cannabis business.

CGCNegative Net Change TLRYNegative Net Change ACBNegative Net Change CRLBFNegative Net Change

Zacks Equity Research

Zacks.com featured highlights Astrana Health, KT, Upbound, Noah Holdings and DXP Enterprises

ASTH, KT, UPBD, NOAH, and DXPE all boast low EV-toEBITDA ratios and rising earnings estimates, making them standout value plays.

KTPositive Net Change DXPENegative Net Change NOAHPositive Net Change UPBDNegative Net Change ASTHNegative Net Change

Zacks Equity Research

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.

FMSNegative Net Change CORNegative Net Change ITGRNegative Net Change HIMSNegative Net Change

Zacks Equity Research

RARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End

Ultragenyx Pharmaceutical and Mereo BioPharma shares tumble as investors await key phase III UX143 osteogenesis data now set for release at year-end.

BAYRYNegative Net Change RARENegative Net Change VRNANegative Net Change MREONegative Net Change

Kaibalya Pravo Dey

Billing or Healing? UnitedHealth's HouseCalls Get a DOJ Checkup

UNH faces a DOJ criminal probe over its HouseCalls billing, raising stakes for the Medicare Advantage giant.

UNHPositive Net Change MOHNegative Net Change CNCNegative Net Change

Ekta Bagri

Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump

Trump revives tariff threats on pharma imports, but industry giants like LLY and JNJ stay unfazed with major U.S. investments underway.

NVSNegative Net Change RHHBYNegative Net Change JNJNegative Net Change LLYPositive Net Change

Zacks Equity Research

Company News for Jul 10, 2025

Companies in The News Are: AMZN, BA, PLTR, UNH

BAPositive Net Change AMZNPositive Net Change UNHPositive Net Change PLTRNegative Net Change

Zacks Equity Research

KALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?

KalVista jumps 36% in a week after the FDA clears Ekterly, the first oral on-demand therapy for hereditary angioedema.

AGENPositive Net Change AMRNNegative Net Change KALVNegative Net Change TAKNegative Net Change

Moumi Mondal

Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?

HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.

JNJNegative Net Change MDTPositive Net Change HOLXNegative Net Change

Zacks Equity Research

ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?

Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.

ABTNegative Net Change BSXNegative Net Change ALGNNegative Net Change CORNegative Net Change

Zacks Equity Research

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.

CNMDNegative Net Change CVSNegative Net Change CORNegative Net Change WGSNegative Net Change

Zacks Equity Research

Should You Continue to Hold STERIS Stock in Your Portfolio Now?

STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.

CAHNegative Net Change CORNegative Net Change STENegative Net Change PAHCNegative Net Change

Zacks Equity Research

Is it Worth Adding Boston Scientific Stock to Your Portfolio Now?

BSX rides on strong MedSurg growth and strategic acquisitions amid currency headwinds.

ABTNegative Net Change BSXNegative Net Change ALGNNegative Net Change CORNegative Net Change